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Abstract
Background: The mycotoxin deoxynivalenol (DON) is highly prevalent in cereals in moderate climates and
therefore pigs are often exposed to a DON-contaminated diet. Pigs are highly susceptible to DON and intake of DON-
contaminated feed may lead to an altered immune response and may influence the pathogenesis of specific bacterial
diseases. Therefore, the maximum guidance level in feed is lowest in this species and has been set at 900 μg/kg feed by
the European Commission. This study aimed to determine the effect of in-feed administration of a moderately high DON
concentration (1514 μg/kg) on the severity of an experimental Mycoplasma hyopneumoniae (M. hyopneumoniae) infection
in weaned piglets. Fifty M. hyopneumoniae-free piglets were assigned at 30 days of age [study day (D)0] to four different
groups: 1) negative control group (NCG; n = 5), 2) DON-contaminated group (DON; n= 15), 3) DON-contaminated and
M. hyopneumoniae-inoculated group (DONMHYO; n = 15), 4) M. hyopneumoniae-inoculated group (MHYO;
n = 15). The piglets were fed the experimental diets ad libitum for five weeks and were monitored during
this period and euthanized at day 35 [27 days post infection (DPI)] or 36 (28 DPI). The main parameters
under investigation were macroscopic lung lesions (MLL) at euthanasia, respiratory disease score (RDS) from
day 8 until day 35, histopathologic lesions and log copies of M. hyopneumoniae DNA detected by qPCR,
determined at the day of euthanasia.
Results: No significant difference was obtained for MLL at euthanasia, RDS (8–35), histopathologic lung
lesions and log copies of M. hyopneumoniae DNA in the DONMHYO and MHYO group and consequently,
no enhancement of the severity of the M. hyopneumoniae infection could be detected in the DONMHYO
compared to the MHYO group.
Conclusions: Under present conditions, the findings imply that feed contaminated with DON (1514 μg/kg)
provided to weaned pigs for five weeks did not increase the severity of an experimental M. hyopneumoniae
infection. Further research is needed to investigate the impact of DON on M. hyopneumoniae infections in a
multi-mycotoxin and multi-pathogen environment.
Keywords: Mycoplasma hyopneumoniae, Experimental, Challenge, Clinical, Impact, Deoxynivalenol, Feed,
Weaned piglets
* Correspondence: Annelies.Michiels@UGent.be
1Department of Reproduction, Obstetrics and Herd Health, Faculty of
Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke,
Belgium
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Michiels et al. BMC Veterinary Research  (2018) 14:190 
https://doi.org/10.1186/s12917-018-1502-4
Background
The mycotoxin deoxynivalenol (DON) is a fungal
metabolite produced mainly by Fusarium grami-
nearum and Fusarium culmorum [1, 2]. Fusarium--
produced mycotoxins, of which by toxicological
viewpoint the trichothecenes DON and T-2 toxin,
zearalenone and fumonisins are the most important
[3], have been reported worldwide in many
cereal-based cropping systems. Fusarium species
have traditionally been associated with temperate ce-
reals, as these fungi require lower temperatures for
growth and mycotoxin production [4]. Indeed, DON
is one of the most common natural mycotoxin con-
taminants of wheat and other small cereal grains
harvested in moderate climate zones [5–7]. Extensive
data on global mycotoxin occurrence showed that
59% of 5819 samples of animal feed tested positive
on DON presence [3, 4, 8]. In low doses, DON
causes anorexia, decreased weight gain and immune
stimulation [2]. Pigs are known to be a very sensitive
animal species to DON, mainly because of the high
oral bioavailability and differences in metabolism of
this mycotoxin compared to other species [2]. In
moderate to high doses (above 840 μg/kg feed), de-
creased feed intake or feed refusal, vomiting and im-
mune suppression are seen [2, 9, 10]. In fact, the EU
(European Union) recommended maximum pig feed
guidance level for DON is 900 μg/kg, which is the
lowest one compared to other farm animal species
for total diets and compounds of total diets. For
adult ruminants and poultry a maximum of 5000 μg/
kg and 2000 μg/kg for calves and lambs are set as
guidance levels [11]. On top of that, the pig con-
sumes a cereal rich diet and DON is frequently de-
tected in wheat, barley, corn and by-products [9, 12].
It is known that DON can have an impact on the
pathogenesis of several bacterial diseases [3, 13, 14]. Ex-
posing porcine ileal loop tissue to a DON-concentration
of 1 μg/ml, potentiated the inflammatory response and
significantly enhanced Salmonella Typhimurium inva-
sion in and passage of the bacterium across the intestinal
epithelium [15]. Furthermore, DON (0.025 μg/ml)
induced an enhanced uptake of Salmonella Typhimur-
ium in porcine macrophages, indicating the capacity of
DON to modulate the innate immune system, and thus
to increase the susceptibility of the pig to Salmonella
Typhimurium infections [16]. Deoxynivalenol might,
due to the immunomodulatory effect on the host and/or
the immediate impact on the pathogen, have an impact
on the course of respiratory infectious diseases in swine.
However only limited in vivo information is available. A
three-week ingestion period of feed contaminated with
high levels of 2500 μg/kg and 3500 μg/kg DON resulted
in a higher viremia and lung viral load in case of a
Porcine Circovirus type 2 (PCV2) infection, and a lower
body weight gain, more lung lesions and mortality in
porcine reproductive and respiratory syndrome virus
(PRRSv)-infected pigs, respectively [17, 18]. Pigs receiv-
ing fumonisin B1 in a concentration of 10,000 μg/kg
feed, and dually infected with Bordetella bronchiseptica
(B. bronchiseptica) and Pasteurella multocida, (P. multo-
cida) were at greater risk to develop pneumonia and had
an increase of the extent and severity of the pathological
changes compared to dually infected pigs that did not
receive fumonisin B1 [19]. Oral gavage of P. multoci-
da-infected pigs with a crude extract of fumonisin B1 in
a concentration of 500 μg/kg body weight (BW) per day
for a period of seven days resulted in the pigs coughing
more, in increased bronchoalveolar lavage fluid total
cells, macrophages and lymphocytes, and resulted in an
increased occurrence of lung lesions compared to the
pigs only infected with P. multocida [20]. Dietary expos-
ure to fumonisin B1 in a concentration of 12,000 μ/kg
feed increased the risk on PRRSv–associated disease [21]
and induced pulmonary edema which may aggravate M.
hyopneumoniae infection [22].
Mycoplasma hyopneumoniae is causing tremendous
economic losses in all intensive pig producing countries
worldwide [23], despite many attempts to control the
disease (enzootic pneumonia) through vaccination strat-
egies and control measures. Consequently, there is a
high prevalence of both M. hyopneumoniae infections
and a high contamination rate of feed with mycotoxins,
more specific DON, in Europe [8]. Therefore, the odds
for a pig to ingest feed contaminated with DON, whilst
simultaneously being infected with M. hyopneumoniae is
high. The present study aimed to investigate the effect of
in-feed administration of DON at a moderately high
level of 1540 μg/kg feed, on the clinical course of an ex-
perimental M. hyopneumoniae infection with two genet-
ically different M. hyopneumoniae strains in weaned
piglets.
Methods
Study animals and experimental design
The study was compliant with all relevant institutional and
European standards for animal care and experimentation.
The experiment was approved by the Ethics Committee for
Animal Experiments of the Faculty of Veterinary Medicine
and Faculty of Bioscience Engineering, Ghent University (ap-
proval number EC2015/112). Fifty M. hyopneumoniae-free
Rattlerow-Seghers piglets (RA-SE Genetics NV, Ooigem,
Belgium) were included in the study. The herd of origin has
been free of M. hyopneumoniae and PRRSv since 2012 based
on repeated serological testing, absence of clinical signs and
pneumonia lesions, and nested polymerase chain reaction
(nPCR) testing on tracheobronchial swabs as previously de-
scribed [24]. The gilts and sows in the herd were vaccinated
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against Erysipelothrix rhusiopathiae and Parvovirus before
insemination. No vaccinations were administered to the pig-
lets. The piglets were weaned on average at 26 days of age
and moved four days later to the experimental facilities of
the Faculty of Veterinary Medicine, Ghent University,
Belgium. The piglets were individually identified by means of
an ear tag. The study design, the different parameters and
timing are summarized in Table 1. Upon arrival (D0) the pig-
lets were randomly allocated to four different groups: 1)
negative control group (NCG; n= 5): sham-inoculated D8,
D9 + control diet, 2) DON-contaminated group (DON; n=
15): sham-inoculated D8, D9 and DON-diet (1514 μg/kg), 3)
DON-contaminated and M. hyopneumoniae-inoculated
group (DONMHYO; n = 15): experimentally inoculated with
M. hyopneumoniae D8, D9 and DON-diet (1514 μg/kg), 4)
M. hyopneumoniae-inoculated group (MHYO; n = 15): ex-
perimentally inoculated with M. hyopneumoniae D8, D9 +
control diet. The number of 15 animals in the treatment
groups enabled to find a difference of 5.26 ± 4.7 in the main
parameter, namely macroscopic lung lesions (two-sided test)
with 95% certainty and a statistical power of 80%. This differ-
ence is biologically relevant and was based on previous re-
search in our research group [25]. The NCG (5 pigs) was
used to verify whether the purchased piglets remained M.
hyopneumoniae negative throughout the study. The different
groups were housed in four different facilities equipped with
absolute filtered chambers (HEPA U15) in order to avoid
cross-infection of M. hyopneumoniae between the different
groups. The pigs had free access to drinking water and were
fed ad libitum.
Mycoplasma hyopneumoniae strains and challenge
infection
The pigs were inoculated with two different strains of
M. hyopneumoniae: a highly virulent strain F7.2C and
low virulent strain F1.12. Both strains had been differ-
entiated and characterized at proteomic level with
Sodium-Dodecyl-Sulphate Polyacrylamide gelelectro-
phoresis (SDS-page) [26] and at genomic level with
Random Amplified Polymorphic DNA (RAPD), Amplified
Fragment Length Polymorphism (AFLP), PCR-Random
Fragment Length Polymorphism (PCR-RFLP) of the p146
gene, Variable Number of Tandem Repeats (VNTR) ana-
lysis of p97, with Multiple-Locus of VNTR Analysis
(MLVA) [27–29] and used in previous studies [24, 25, 30].
Previous research has shown that pigs are often infected
with two or even three genetically different M. hyopneu-
moniae strains [29, 31, 32], and in slaughter pigs infected
with different strains, more lung lesions can be detected
[32]. Therefore, the pigs in the present study were inocu-
lated with two genetically different M. hyopneumoniae
strains, as performed previously by this research group
[18], to mimic the situation in the field. All pigs were
anesthetised via the intramuscular route with 0.22 ml/kg
BW of a mixture of tiletamine, zolazepam (Zoletil 100®,
Virbac, Louvain-la-Neuve, Belgium) and xylazine (Xyl-M®
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athe average age of the pigs at arrival was 26 days, ball pigs of the NCG and DON group, and five pigs of MHYO were necropsied at D35. Ten pigs of MHYO and
all pigs of DONMHYO were necropsied at D36, cRDS was not determined at D0 and D36 because the piglets arrived later than 8 a.m. (hour of performing
coughing score every day) and part of the piglets were already euthanized on D36, respectively, dsham-inoculation was performed with sterile Friis medium,
ehighly virulent strain of M. hyopneumoniae, flow virulent strain of M. hyopneumoniae
NCG negative control group, DON deoxynivalenol contaminated group, DONMHYO deoxynivalenol contaminated +M. hyopneumoniae-inoculated group, MHYO M.
hyopneumoniae-inoculated group, RDS respiratory disease score, BALF bronchoalveolar lavage fluid
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2%, VMD, Arendonk, Belgium) and the pigs of the
DONMHYO and MHYO groups were endotracheally in-
oculated with 7 ml of inoculum containing 107 CCU/ml
of strain F7.2C on D8 and 7 ml of inoculum containing
107 CCU/ml of strain F1.12A on D9. On both inoculation
days, the pigs of the NCG and DON group were endotra-
cheally sham-inoculated with 7 ml of sterile Friis medium.
At D35 or D36 of the experiment, the pigs were eutha-
nized using deep anaesthesia by intramuscularly adminis-
tering 0.3 ml/kg BW of a mixture of tiletamine, zolazepam
(Zoletil 100®, Virbac, Louvain-la-Neuve, Belgium) and
xylazine (Xyl-M® 2%, VMD, Arendonk, Belgium), followed
by exsanguination. For practical reasons and to avoid M.
hyopneumoniae contamination of the samples, all pigs of
the NCG and DON group were euthanized at D35,
followed by five animals of the MHYO group. All the
other animals of the MHYO and all animals of the
DONMMHYO group were necropsied on D36.
Deoxynivalenol contaminated diet
A commercial antibiotic-free diet for weaned piglets was
purchased (Leievoeders N.V., Waregem, Belgium). Before
purchasing the feed, a sample of the batch was tested with
liquid chromatography-tandem mass spectrometry
(LC-MS/MS) according to Monbaliu et al. [33, 34] for the
presence of DON, 3-Acetyldeoxynivalenol (3-ADON),
zearalenone and fumonisin B1+ B2, the levels were below
the reporting limit of 50 μg/kg, 50 μg/kg, 10 μg/kg and
50 μg/kg, respectively. The piglets of the NCG and MHYO
groups were fed this commercial diet from D0 until D35/
36. A part of the purchased feed (1300 kg) was transported
to the laboratory of the Department of Applied Biosciences
(Faculty of Bioscience Engineering, Ghent University) to
add the target concentration of 1800 μg/kg feed DON.
This procedure was followed: the reference strain Fusar-
ium graminearum (F. graminearum) MUCL 42841
(Mycothèque de l’Université catholique de Louvain) was
used to produce the DON-culture. The strain was grown
in liquid mineral (MIN) medium supplemented with
L-arginin as a selective nitrogen source, as previously de-
scribed by Gardiner et al. [35]. After 14 days of cultivation,
the culture was filtered and centrifuged. The obtained con-
centration of DON was determined with LC-MS/MS by
adding 150 μl of the resulting undiluted MIN medium to
5 g of certified blank wheat standard (Sigma Aldrich, Over-
ijse, Belgium). In total, 7535 mg/kg DON was quantified
and 1076 mg/kg acetylated DON (3-ADON + 15-ADON)
in the grown DON-culture. Next to the presence of DON,
the inoculum was tested with LC-MS/MS for the presence
of other F. graminearum trichothecenes such as nivalenol,
neosolaniol, fusarenon-X, diacetoxyscirpenol, HT-2 toxin
and T-2 toxin, and results were below the detection limit.
Also no zearalenone was detected. Eight l of inoculum
were obtained for preparation of 1300 kg of
DON-contaminated feed in a concentration aimed at twice
the recommended maximum pig feed level of 900 μg/kg or
1800 μg/kg DON. First, 2.67 l of the inoculum was mixed
with 10 kg of feed to obtain a thoroughly mixed premix of
the DON-contaminated feed. Subsequently, the premix
with inoculum was added to 433.3 kg of feed in a feed mill
and thoroughly mixed for at least 40 min. The same pro-
cedure was repeated twice, to obtain the total amount of
1300 kg of DON-contaminated feed in a concentration of
1800 μg/kg and the feed was collected again in the original
25 kg bags of the feeding company. After preparation of
the contaminated feed, a mixed sample originating from
three DON-contaminated feed bags was taken and was
submitted for LC-MS/MS to obtain the true
DON-concentration of the contaminated feed. The results
of the LC-MS/MS of the contaminated feed were 407 ±
120 μg/kg DON, 280 ± 100 μg/kg 3-ADON and 827 ±
300 μg/kg 15-ADON, resulting in a total DON and acety-
lated DON (3-ADON + 15-ADON)-concentration of
1514 μg/kg in the contaminated feed sample. This feed
was used in the DON and DONMHYO-groups from D0
until D35/36 of the study.
Clinical and performance parameters
From D0 until D35/36 onwards, the piglets were observed
daily at 8 a.m. for at least half an hour by the same re-
searcher to assess appetite, faecal consistency and pres-
ence of dyspnea and tachypnea. A faecal consistency score
was used to evaluate the faeces found on the pen floor be-
fore cleaning [36]: 1 (firm and shaped), 2 (soft and
shaped), both addressed as a normal faecal consistency in
pigs, 3 (loose) and 4 (watery), with scores 3 and 4 consid-
ered as abnormal. Daily, from D1 until D35 a respiratory
disease score (RDS), ranging from 0 to 6 was recorded ac-
cording to Halbur et al. (1996) [37]. Score 0 was obtained
when a pig did not cough. Score 1, 3 and 5 were respect-
ively designated as mild, moderate and severe couging
after encouraged move. Score 2, 4, 6 were respectively ob-
tained when mild, moderate and severe coughing in rest
was present.The RDS was not determined at D0 and D36,
as the pigs arrived later than 8 a.m. at the facilities and
already part of the animals was euthanized on D35. The
daily RDS values were averaged for the following periods:
D1–7, D8–35/36 and D1–35/36. All pigs were weighed
(kg) at the day of arrival (D0), the first inoculation day
(D8) and the day of euthanasia (D35/36). The average
daily gain (ADG, kg/pig/day) was calculated from D0–7,
D8–35/36 and D0–35/36 by subtracting the starting
weights from the final weights, divided by the number of
days during that period.
Macroscopic and histopathologic lung lesions
The lungs were removed and macroscopic lung lesions
(MLL) (D35/36) were determined according to Hannan
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et al. (1982) [38] from each pig. Consequently, the lungs
were transported to the laboratory of the Department of
Pathology, Bacteriology and Avian Diseases, Faculty of
Veterinary Medicine, Ghent University from the nec-
ropsy rooms from the experimental facilities in the same
department and from each lung in each pig, samples
from the right apical, cardiac and diaphragmatic lung
lobes were collected. In case a lesion was present, a sam-
ple was collected including both healthy and affected
lung tissue, at the border of the lesion. The 10% neutral
formalin fixed and paraffin embedded samples were
stained with hematoxylin and eosin. Using light micros-
copy the samples were investigated and scored for the
degree of peribronchiolar and perivascular lymphohistio-
cytic infiltration and nodule formation (cuffing) [39].
The scoring system ranged from 1 to 5, with score 1 and
2 considered not to be related with M. hyopneumoniae
infection as previously described [24, 39, 40].The per-
centage of air (percentage of lung area occupied by air)
was examined by means of an automated image analysis
system (Leica application suite AF Lite (Diegem,
Belgium) and image J (Bethesda, Maryland, USA) [41].
This parameter is inversely proportional to the lympho-
histiocytic infiltration in the lung tissue and the
intrabronchiolar-and bronchial exudate [25].
Quantitative PCR for M. hyopneumoniae
Two weeks post inoculation (PI) (D21) of the high viru-
lent strain F7.2C (D8), bronchoalveolar lavage (BAL)
fluid from all pigs, while conscious was collected. After
snaring the pigs and opening their mouth with a gag, a
catheter (Portex® Dog Catheter with Female Luer
Mount, Smiths Medical International Ltd. Kent, United
Kingdom) was inserted allowing to flush the lungs with
10 ml of sterile phosphate buffered saline (PBS). The
PBS fluid was subsequently aspirated. At the day of nec-
ropsy (D35/36) the head bronchus of the left part of the
lung was flushed with 10 ml of sterile PBS before collec-
tion of the histopathological samples. After collection,
the BAL fluids were stored at − 70 °C until they were
analysed. The DNA was extracted with the DNeasy
Blood & Tissue kit (QIAGEN, Qiagen Benelux, B.V.,
Antwerp, Belgium) with the DNA Purification protocol
for bloods or bloody fluids (spin protocol) on 200 μl of
BAL fluid according to the manual instructions and
quantitative PCR (qPCR) was performed as previously
described to detect the number of M. hyopneumoniae
organisms [42]. Briefly, after DNA-extraction, qPCR was
performed with primers p102f (5’GTCAAAGTCAAAGT
CAGCAAAC 3′) and p102r (5’AGCTGTTCAAATGC
TTGTCC 3′) using SensiMixTM SYBR (Bioline GmbH,
Luckenwalde, Germany) in the CFX384 real-time PCR
detection system (Bio-Rad, Nazareth, Belgium). A ten-
fold dilution series of M. hyopneumoniae DNA of strain
F7.2C was used to convert the threshold values to the
number of M. hyopneumoniae organisms. Values below
the dilution of 1.50 × 101 (1.18 log copies) were consid-
ered as negative [31, 42].
Serology
A blocking ELISA (IDEIA™ Mycoplasma hyopneumoniae
EIA kit, Oxoid Limited, Hampshire, UK) was performed
according to the instructions in the protocol manual and
as previously described [24] to detect antibodies against
M. hyopneumoniae in the blood collected at D28, D21
and at necropsy (D35/36). Sera with optical density <
50% of the average value of the OD-buffer control were
considered to be positive. All values above or equal to
50% of the average value of the OD-buffer control were
classified as negative .
Routine bacteriological culture on bronchoalveolar lavage
fluid
Ten μl of BAL fluid collected at necropsy (D35/36) of
each pig was inoculated on Columbia agar supplemented
with 5% sheep blood (Oxoid, Hampshire, UK) with a
Staphylococcus pseudintermedius streak for bacterio-
logical examination [43]. Plates were incubated for 48 h
in a 5% CO2-enriched environment at 35 °C for identifi-
cation of respiratory bacteria in the lungs. All macro-
scopically different colonies were identified to the
species level (score value > 2.000) with a Bruker Daltonic
Microflex LT Biotyper Biotyper MALDI-TOF mass spec-
trometer by using the direct transfer method and
α-cyano-4-hydroxycinnamic acid (HCCA) as matrix, ac-
cording to the manufacturer’s guidelines. The spectra
were obtained and analysed with the MBT Compass
software version 3.1. (Bruker Daltonik), which included
a database of 6903 mean spectra projections.
Statistical analysis
The independent variable in the statistical analyses was
‘group’: NCG, DON, DONMHYO and MHYO-group.
The dependent variables were RDS, weight, ADG, MLL,
histopathology and percentage of air, qPCR-results, per-
centage of M. hyopneumoniae qPCR-positive samples,
M. hyopneumoniae specific AB expressed in OD values
and percentage of ELISA M. hyopneumoniae positive
samples. These variables were all run in separate models
with ‘pig’ as statistical unit and no additional factors in-
cluded into the model. The normality of the data was in-
vestigated by means of descriptive statistics, except for
the binary data (M. hyopneumoniae qPCR positive sam-
ples and ELISA M. hyopneumoniae positive samples).
The parameters BW, ADG and percentage air analysis
were normally distributed and a one-way analysis of
variance (ANOVA) test was used. In case of the RDS, a
repeated measures ANOVA was performed. Scheffé’s
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post-hoc test was used to make pair-wise comparisons.
The qPCR-results and M. hyopneumoniae specific anti-
bodies were not normally distributed and therefore, a
non-parametric Kruskal-Wallis test was used, with the
Dunn-Bonferroni approach to make pair-wised compari-
sons, as well for MLL and histopathology results. In case
of the normally distributed data, the mean and standard
deviation (SD) were reported, in case of the
non-parametric data, the median and the interquartile
range were reported. All analyses for these parameters
were performed with SPSS 23 for Windows (SPSS inc.
Illinois, USA). Percentage of seropositive pigs and per-
centage of pigs testing positive with qPCR in each group
were analyzed using binomial logistic regression (R ver-
sion 3.3.1) [44]. The results were considered to be statis-
tically significant when P < 0.05.
Results
Clinical and performance parameters
In none of the groups, feed refusals or vomiting were ob-
served. No tachypnea, nor dyspnea were observed in any
of the groups. Post-weaning diarrhoea was observed from
D0 onwards until D3 in all groups, therefore all pigs were
treated IM with Colistin sulphate (Colivet ‘S’, Prodivet,
Eynatten, Belgium) from D0 onwards for 5 days, according
to the product leaflet. The post weaning diarrhoea lasted
until D8, D3, D3 and D7 in NCG, DON, DONMHYO and
MHYO, respectively. In three groups some pigs with fae-
cal consistency score 3 were noticed throughout the study:
in NCG two pigs at D20 and D23 respectively, in DON
one pig at D13 and in DONMHYO two pigs at D20 and
D23, respectively. In MHYO, normal faecal consistency
was observed throughout the study. Coughing was not ob-
served in the NCG. All results of the different time pe-
riods for this parameter in the study are shown in Table 2
(RDS 1–7, RDS 8–35 and RDS 1–35). The RDS from the first
inoculation day onwards until euthanasia (RDS 8–35) were
0 ± 0, 0.0071 ± 0.028, 1.04 ± 0.82, 1.14 ± 0.92 for NCG,
DON, DONMHYO and MHYO, respectively (P < 0.001).
No statistically significant differences were obtained be-
tween all groups for D1–7. For D8–35 and D1–35 a statis-
tically significant difference was obtained between the
experimentally infected (DONMHYO and MHYO) and
non-infected pigs (NCG and DON) (P < 0.001). However,
no statistically significant differences were obtained for
DONMHYO and MHYO groups in each time period of
the study (Table 2). The daily course of RDS 1–35 for each
group is shown in Fig. 1.
Table 2 Results of the clinical parameters, macroscopic and microscopic lung lesions in the different experimental groups
Parameter Groups
NCG (n = 5) DON (n = 15) DONMHYO (n = 15) MHYO (n = 15) P-value
RDS
D1–7 0 ± 0 0 ± 0 0 ± 0 0 ± 0 1.00
D8–35 0 ± 0a 0.01 ± 0.03a 1.04 ± 0.82b 1.14 ± 0.92b < 0.001
D1–35 0 ± 0a 0.01 ± 0.03a 0.83 ± 0.84b 0.91 ± 0.94b < 0.001
Weight ± SD (kg)
D0 6.37 ± 1.09 6.39 ± 0.92 6.38 ± 1.04 6.42 ± 1.23 1.00
D8 7.70 ± 1.13 8.04 ± 1.27 8.20 ± 1.08 8.11 ± 1.90 0.92
D35/36 20.10 ± 2.33 19.45 ± 3.83 21.02 ± 3.18 21.75 ± 4.36 0.38
ADG (kg/pig/day)
D0–8 0.52 ± 0.14 0.53 ± 0.19 0.56 ± 0.15 0.67 ± 0.17 0.12
D0–35/36 0.39 ± 0.06 0.37 ± 0.11 0.41 ± 0.08 0.43 ± 0.10 0.41
D8–35/36 0.46 ± 0.08 0.42 ± 0.13 0.46 ± 0.10 0.49 ± 0.10 0.37
MLL, histopathology and percentage of air D35/36
MLL 0 ± 0a 0 ± 0a 2.77 ± 3.22b 5.87 ± 7.32b < 0.001
Histopathology 1.70 ± 0.20a 2.00 ± 0.30a 2.40 ± 0.80b 2.40 ± 0.90b < 0.001
Percentage of air (%) 45.94 ± 6.54 46.85 ± 6.86 49.75 ± 9.90 46.96 ± 8.51 0.25
Respiratory disease score (RDS), bodyweight, average daily weight gain (ADG), macroscopic lung lesions (MLL), histopathology score of the lungs and percentage
of air in the lungs for NCG, DON group, DONMHYO group, MHYO group
The parameters bodyweight, ADG, percentage of air analysis were analysed by means of one way analysis of variance, the parameter RDS with a repeated
measures analysis of variance, in both cases with Scheffé post-hoc test to make pair-wised comparisons, therefore means ± SD are reported. The parameter MLL
and histopathology were analysed with Kruskal-Wallis test and the Dunn-Bonferroni approach to make pair-wised comparison, therefore medians and interquartile
range are reported. Different superscripts in one row are statistically different (P < 0.05)
NCG: negative control group, DON: deoxynivalenol contaminated group, DONMHYO: deoxynivalenol contaminated +M. hyopneumoniae-inoculated group, MHYO:
M. hyopneumoniae-inoculated group, SD: standard deviation, n number, D Day of the study, ADG average daily gain, RDS respiratory disease score, MLL
macroscopic lung lesions
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There were no significant differences between the
groups for the parameter BW and the ADG during the
different time periods (Table 2).
Macroscopic and histopathologic lung lesions
The MLL of the NCG, DON, DONMHYO and
MHYO groups were 0 ± 0, 0 ± 0, 2.77 ± 3.22 and 5.87
± 7.32, respectively (P < 0.001). The histopathological
lung lesions were 1.70 ± 0.20, 2.00 ± 0.30, 2.40 ± 0.80
and 2.40 ± 0.90 for the NCG, DON, DONMHYO and
MHYO group, respectively (P < 0.001). The percentage
of air was 45.94 ± 6.54, 46.85 ± 6.86, 49.75 ± 9.90 and
46.96 ± 8.51 for NCG, DON, DONMHYO and
MHYO, respectively (P = 0.25). There were no statisti-
cally significant differences between the DONMHYO
and MHYO groups for these above-mentioned param-
eters, however there were statistically significant dif-
ferences between the experimentally infected
(DONMHYO and MHYO) and non-infected pigs
(NCG and DON) (P < 0.001), except for the parameter
percentage of air analysis (P = 0.25) (Table 2).
Quantitative PCR for M. hyopneumoniae
The samples of the NCG and DON group remained
negative throughout the study. The qPCR results at
D21 were 0.05 ± 0.37, 0.63 ± 0.81, 3.92 ± 2.60 and 3.24
± 1.91 (P < 0.001) and at D35/36 0.80 ± 0.70, 0.29 ±
1.09, 4.05 ± 1.38 and 4.20 ± 1.00 (P < 0.001) for NCG,
DON, DONMHYO and MHYO, respectively. There
were no significant differences between the DONM-
HYO and MHYO group, however there were statistically
significant differences between the experimentally infected
(DONMHYO and MHYO) and non-infected pigs (NCG
and DON) (P < 0.001) for D21 and D35/36 (Table 3).
Serology
The serological results are presented in Table 3. All pigs
of the NCG and DON remained serologically negative
throughout the study. The OD-values of the serological
results at D35/36 were 1.15 ± 0.27, 1.16 ± 0.18, 0.25 ±
0.18 and 0.23 ± 0.09 for the NCG, DON, DONMHYO
and MHYO, respectively. At necropsy (D35/36), all pigs
of DONMHYO and MHYO were serologically positive.
Routine bacteriological culture on bronchoalveolar lavage
fluid
Few colonies of Streptococcus suis were isolated from
one pig of both the DONMHYO (1/15) and MHYO (1/
15) groups. In addition, few colonies of B. bronchiseptica
were isolated from one pig of DON (1/15) and four pigs
of MHYO (4/15).
Discussion
In the present study, the outcome of the main parame-
ters (RDS, MLL, histopathological lesions and log copies
of M. hyopneumoniae DNA in bronchoalveolar lavage
Fig. 1 Course of average respiratory disease score (RDS) from day 1 until the day of necropsy (D 35). Average RDS from D1 until D35
in the negative control group (NCG), the DON-contaminated group (DON), DON-contaminated and M. hyopneumoniae-inoculated group (DONMHYO),
and M. hyopneumoniae-inoculated group (MHYO). The challenge infections were performed on D8 (a highly virulent M. hyopneumoniae strain F7.2C)
and D9 (a low virulent strain F1.12) in DONMHYO and MHYO. The NCG and DON were sham-inoculated with sterile Friis medium on D8 and D9
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fluid) was not statistically different in M. hyopneumoniae
infected pigs that received or did not receive
DON-contaminated feed. This indicates that ingestion of
DON-contaminated feed at a concentration of 1514 μg/
kg, exceeding the maximum guidance level for pigs ac-
cording to EU regulation, did not aggravate the severity
of an experimental M. hyopneumoniae-infection in
weaned piglets.
The challenge infection was successful as all animals
in the M. hyopneumoniae inoculated groups (MHYO
and DONMHYO group) coughed, showed lung lesions
(except for one animal in the MHYO group), serocon-
verted and M. hyopneumoniae-DNA was detected in
BAL fluid at necropsy. The results obtained in the
M. hyopneumoniae challenged pigs (DONMHYO and
MHYO group) differed significantly from the
non-challenged pigs (DON group, NCG). The latter pigs
remained serologically negative throughout the entire
study period and no M. hyopneumoniae- DNA was de-
tected in BAL fluid two weeks post-inoculation, nor at
necropsy. The obtained data in the challenged groups
were comparable with a previous study performed by
our research group with the same challenge model [24],
demonstrating the repeatability of the model. The two
M. hyopneumoniae-strains were not administered on the
same day, as the infection model practiced at our re-
search group uses seven ml inoculum containing 107
CCU of the strain/ml [31]. It is not known whether pig-
lets of four to five weeks of age (on average 26 days, D0
at arrival and inoculation at D8) are able to cope with
twice the inoculum volume (14 ml for both strains). In
addition, it is not known whether both strains will grow
next to each other, or whether one strain will overgrow
the other strain consuming most of the nutrients, when
these M. hyopneumoniae-strains are grown in the same
culture flask. Consequently, it was decided to challenge
the piglets on two consecutive days.
In the present study, DON was aimed to be adminis-
tered at two times the maximum guidance level of DON
advised by the European commission for pigs (1800 μg/
kg feed) [11]. This dose was selected as Madson et al.
[45] stated that moderate (1000–5000 μg/kg feed) to
high concentrations (> 5000 μg/kg feed) are associated
with delayed or supressed immune responses due to
leukocyte apoptosis and resulting in increased disease
susceptibility [45, 46]. It was demonstrated that a
dose-related decrease in daily feed intake is observed
when administering DON-supplemented feed to pigs,
and that this effect was mostly significant to the control
feed in the range of 2000 μg/kg – 4000 μg/kg [47–49].
Therefore, a dose below this range was chosen to be ad-
ministered to the pigs in this study to limit feed refusals
and to avoid hampering of DON possibly influencing the
investigated parameters. The commercial, un-spiked feed
Table 3 Results of M. hyopneumoniae-DNA detection in the BALF and serology in the different experimental groups
Parameter Groups
NCG (n = 5) DON (n = 15) DONMHYO (n = 15) MHYO (n = 15) P-value
qPCR (log copies of M. hyopneumoniae DNA /ml BALF) ± SD
D21 0.05 ± 0.37a 0.63 ± 0.81a 3.92 ± 2.60b 3.24 ± 1.91b < 0.001
D35/36 0.80 ± 0.70a 0.29 ± 1.09a 4.05 ± 1.38b 4.20 ± 1.00b < 0.001
Percentage of M. hyopneumoniae qPCR positive samples (n of positive samples/total n of samples tested)
D21 (%) 0 (0/5)a 0 (0/15)a 87 (13/15)b 93 (14/15)b < 0.001
D35/36 (%) 0 (0/5)a 0 (0/15)a 100 (15/15)b 100 (15/15)b < 0.001
M. hyopneumoniae specific AB expressed in OD-values ± SD
D8 1.68 ± 0.23 1.83 ± 0.34 1.71 ± 0.19 1.70 ± 0.19 0.27
D21 1.15 ± 0.22a 1.29 ± 0.23a 1.16 ± 0.36ab 0.94 ± 0.26b 0.001
D35/36 1.15 ± 0.27a 1.16 ± 0.18a 0.25 ± 0.18b 0.23 ± 0.10b < 0.001
Percentage of ELISA M. hyopneumoniae positive samples (n of positive samples/total n of samples tested)
D8 (%) 0 (0/5) 0 (0/15) 0 (0/15) 0 (0/15) 1.00
D21 (%) 0 (0/5) 0 (0/15) 0 (0/15) 13 (2/15) 0.17
D35/36 (%) 0 (0/5)a 0 (0/15)a 100 (15/15)b 100 (15/15)b < 0.001
Respiratory disease score (RDS), bodyweight, average daily weight gain (ADG), macroscopic lung lesions (MLL), histopathology score of the lungs and percentage
of air in the lungs for NCG, DON group, DONMHYO group, MHYO group
The parameter qPCR and M. hyopneumoniae specific AB were analysed with a non-parametric Kruskal-Wallis and the Dunn-Bonferroni approach to make
pair-wised comparisons, therefore median and interquartile range are reported. The prevalence of M. hyopneumoniae qPCR positive samples and the
prevalence of ELISA M. hyopneumoniae positive samples were analysed with binomial logistic regression. Different superscripts in one row are statistically
different (P < 0.05)
NCG: negative control group, DON: deoxynivalenol contaminated group, DONMHYO: deoxynivalenol contaminated + M. hyopneumoniae-inoculated group, MHYO:
M. hyopneumoniae-inoculated group, Different superscripts in one row are statistically different (P < 0.05), n number, SD standard deviation, D Day of the study, M.
hyopneumoniae: Mycoplasma hyopneumoniae, AB antibodies, OD optical densities
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was tested before the start of the study, not only for the
presence of DON, but also for zearalenone and fumoni-
sin B1 + B2, to avoid these components having an effect
in the feed of the control groups (MHYO group, NCG)
and avoiding an additional or synergistic effect to the
DON-toxicity in the DON-spiked groups (DON group,
DONMHYO group) [46]. After preparation of the con-
taminated feed, a mixed feed sample from three
DON-contaminated feed bags was submitted to LC-MS/
MS to detect the DON-concentration and to ensure
thorough mixing of the DON-inoculum in the feed. The
results of the LC-MS/MS was 1514 μg/kg of DON and
acetylated forms and deviated only slightly from the tar-
get concentration of 1800 μg/kg. Cytotoxicity of the pro-
duced DON in the study was not tested on beforehand,
as the deleterious effects of DON in the pigs are known
and the same DON inoculation method in pig feed was
already successfully used in a study by Goossens et al.
[50]. In the latter study, the in vivo effect of DON on in-
testinal damage influencing the resorption of doxycyc-
line was determined in pigs.
It remains to be elucidated why no impact of DON in
the pigs was observed in the present study. The degree
of susceptibility of certain breeds/lines to the effects of
DON might be one explanation [51]. For instance a
lower severity in porcine circovirus type 2 associated
histopathological lesions has been shown for Piétrain
compared to landrace pigs [52], but so far no studies
have assessed the impact of genetic differences in sensi-
tivity to the effects of DON.
No feed-refusals were observed in the pigs adminis-
tered the DON-contaminated feed. The minimum
emetic dose for orally distributed DON in pigs is
100 μg/kg [53], yet vomiting was not observed in this
study. The reason why this did not occur is unclear. It
must be noted that the observation period of the pigs
(30 min. of RDS-scoring, 15 min. Feeding and cleaning
in the morning, 10 min. of observation and cleaning in
the evening) was fairly short compared to the time the
pigs spent in the facilities. However, the main researcher
was always present after providing the feed to identify
possible sick pigs, as most healthy pigs start eating im-
mediately after providing the feed and Young et al., [54]
observed that vomiting occurs within minutes after
ingesting the DON-contaminated feed. Pestka et al. [53]
stated that vomiting due to DON-contaminated feed, is
more likely if the feed is ingested at once and not via
smaller portions throughout the day. The contaminated
feed and hence the DON in the DONMHYO and DON
pigs, was consumed throughout the day as the pigs were
fed ad libitum and had freely access to the feed.
The M. hyopneumoniae-infected pigs administered the
DON-supplemented feed did not have a higher RDS com-
pared to the pigs only infected with M. hyopneumoniae.
No other studies are available investigating the impact of
DON on respiratory tract disease signs in M. hyopneumo-
niae-infected pigs. However the effect of fumonisin B1 in
combination with M. hyopneumoniae or the effect of
DON on other pathogens has been studied. Pósa et al.,
[22] studied the effect of 20,000 μg/kg fumonisin B1 on
M. hyopneumoniae-infected pigs, however no firm conclu-
sions could be drawn regarding the difference in coughing
between the M. hyopneumoniae-infected pigs with or
without fumonisin B1 supplementation in the feed. Halloy
et al. [20] investigated the impact of fumonisin B1 admin-
istered orally (500 μg/kg BW per day, seven days) in P.
multocida-infected pigs and concluded that these pigs
coughed more compared to the pigs only infected with P.
multocida.
It is known that M. hyopneumoniae infections can nega-
tively influence production parameters, such as ADG [55].
Deoxynivalenol ingestion in pigs may result in reduced
feed intake, and subsequently decrease ADG [51, 56, 57].
In the present study, DON did not decrease ADG in the
M. hyopneumoniae inoculated animals. This result is in
agreement with Accensi et al. [9] (840 μg DON/kg feed),
Gerez et al. [46] (1500 μg DON/kg feed), and Savard et al.
[17]. The latter authors studied the impact of DON (2500
and 3000 μg DON/kg feed) in pigs that were simultan-
eously infected with PCV2. Pósa et al., [22], did not find
an effect of fumonisin B1 (20, 000 μg/kg) on ADG in M.
hyopneumoniae-infected pigs. Rotter et al. [58] observed
an adaptation of pigs to oral ingestion of Fusarium myco-
toxins from one week onwards. In that study, pigs were
fed a diet mixed with naturally contaminated corn
(28,700 μg/kg DON, 8600 μg/kg 15-ADON and1,100 μg/
kg ZEA) to obtain DON-concentrations of 750, 1500 or
3000 μg DON /kg feed during 28 days. During the first
week, the exposed pigs had lower weight gains than the
pigs fed a non-contaminated control feed. At the end of
the study, however, the overall weight gains did not differ
anymore between these groups. This adaptation might be
one of the reasons why we did no see an effect of DON on
daily growth. The relative low number of pigs, followed up
during a limited period of time, which is inherent in ex-
perimental infection studies like ours, also makes it diffi-
cult to obtain a statistical significant difference in daily
growth [31, 59, 60]. No effect of DON ingestion on the
macroscopic and histopathological lung lesions was ob-
served in the M. hyopneumoniae infected group. This
finding is in agreement with Pósa et al. [19], who neither
saw a statistical difference in macroscopic lung lesions
between the B. bronchiseptica and P. multocida
dually-infected groups with or without supplementation
of fumonisin B1 in the feed (10,000 μg/kg) of
three-day-old piglets. Savard et al. (2015) on the other
hand, did observe an effect of DON-supplementation in
the feed (3500 μg/kg, three weeks) on macroscopic lung
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lesions in PRRSv-infected pigs [51]. In this study,
DON-ingestion did not influence the number of log cop-
ies detected in the M. hyopneumoniae infected animals.
Similarly, Savard et al. [61] did not observe an effect of
DON-contamination on the presence of viral RNA, mea-
sured with qPCR, in PRRSv-infected pigs. It is not clear
why the obtained effects of dietary DON vary among ex-
periments, It might be explained by different factors such
as starting weight or age of the pigs, the contamination
source of DON (natural versus artificial contamination),
presence of other known or unknown undetected fungal
metabolites or pathogens, duration of the study (adapta-
tion), number of pigs used in the study, gender of the pigs,
health status, nutritional balance of the pig and statistical
design of the study [10, 62, 63]. It is not known why DON
did not influence a M. hyopneumoniae infection under the
circumstances in this study. Deoxynivalenol has a good
distribution in the lung of the pig [64]. However, as M.
hyopneumoniae is attached to the cilia of the upper re-
spiratory tract and does not invade the parenchyma of the
lung [23, 65, 66], it might be that DON is not able to exert
its effect on the pathogen. More research is needed to in-
vestigate this relationship in pigs, for instance by in vitro
tests on pig tracheal explants. On the other hand discrep-
ancies have been reported between in vivo (higher viremia
in pigs exposed to DON in the feed) and in vitro (de-
creased PRRSv replication in MARC-cells) effects of DON
on PRRSv [18, 61], thus extrapolation of in vitro results to
in vivo effects has to be done cautiously.
Conclusions
No effect was observed of DON contamination in a mod-
erately high dose in the feed on the severity of an experi-
mental M. hyopneumoniae infection in weaned piglets. In
the field, however, the impact of DON-contaminated feed
on a M. hyopneumoniae-infection might be more
expressed, because mostly multi-mycotoxin contamin-
ation of the feed occurs [3, 52–54], the pigs can be ex-
posed to DON-contaminated feed for a longer period
than the five week exposure period in this study, often
suboptimal housing and climate conditions may prevail
and other pathogens may be present [55, 56]. Further re-
search should assess the impact of DON on M. hyopneu-
moniae infections under these multi-pathogen and
multi-mycotoxins circumstances and investigating the im-
pact of DON in vitro on M. hyopneumoniae in tracheal
explant cells. More research could also focus on factors
influencing the effect on DON such as health status, gen-
der, age, and possible genetic resistance of the pigs.
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